Chronic Lymphocytic Leukemia Clinical Trials

A listing of Chronic Lymphocytic Leukemia medical research trials actively recruiting patient volunteers. Search for closest city to find more detailed information on a research study in your area.

Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 315 clinical trials
huCART19-IL18 in NHL/CLL Patients

The purpose of this study is to find the maximum dose of huCART19-IL18 cells that is safe for use in humans with Non-Hodgkin Lymphoma (NHL) and Chronic Lymphocytic Leukemia (CLL).

lymphoma
chronic lymphocytic leukemia
leukemia
  • 0 views
  • 03 Nov, 2021
  • 1 location
Effects of Nicotinamide in Patients With Chronic Lymphocytic Leukemia (CLL) With History of Non-melanoma Skin Cancers (NMSC)

This is a randomized, phase II, double-blind, placebo-controlled trial with planned crossover to the intervention arm after 1 year. Consenting patients with CLL who have had at least one

gilbert's syndrome
cancer
chronic lymphocytic leukemia
  • 0 views
  • 26 Mar, 2022
  • 1 location
Pneumococcal Pneumonia Vaccine Series (PCV13 and PPSV23) in Patients With Chronic Lymphocytic Leukemia Associated Immunodeficiency, PROTECT CLL Trial

This phase II trial tests whether the pneumococcal pneumonia vaccine series (PCV13 and PPSV23) works to mount an effective immune response in patients with chronic lymphocytic leukemia. PCV13

lymphoma
venetoclax
chronic lymphocytic leukemia
  • 0 views
  • 16 May, 2022
  • 1 location
Study of Zanubrutinib, Obinutuzumab, and Venetoclax in Patients With Chronic Lymphocytic Leukemia (CLL) or Small Lymphocytic Leukemia (SLL)

, and venetoclax, given in combination as a treatment for CLL and/or SLL.

obinutuzumab
flow cytometry
residual tumor
mantle cell lymphoma
neutrophil count
  • 22 views
  • 07 Oct, 2022
  • 7 locations
Venetoclax-Obinutuzumab +/- Acalabrutinib in R/R CLL

This research study is studying a combination of drugs as a possible treatment for chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL). The names of the study drugs

venetoclax
gilbert's syndrome
obinutuzumab
acalabrutinib
lymphoma
  • 0 views
  • 22 Aug, 2021
  • 3 locations
Personalized Multi-peptide Vaccination in CLL Patients

The aim of this study is to evaluate the efficiency along with safety and toxicity of a personalizied multi-peptide vaccine in combination with the TLR1/2 ligand XS15 in CLL patients undergoing

flow cytometry
remission
ibrutinib
lymphocytosis
thrombocytopenia
  • 0 views
  • 18 Sep, 2021
  • 1 location
Phase I Clinical Trial of Human AntiCD19 Chimeric Antigen Receptor T Cells for Treatment of Relapsed or Refractory Lymphoid Malignancies (Non-Hodgkin Lymphoma, Acute Lymphoblastic Leukemia, Chronic Lymphocytic Leukemia)

The purpose of this study is to determine if it is possible to treat relapsed or refractory lymphoid malignancies (Non-Hodgkin Lymphoma, Acute Lymphoblastic Leukemia, Chronic Lymphocytic

gilbert's syndrome
cyclophosphamide
flow cytometry
remission
chronic lymphocytic leukemia
  • 0 views
  • 24 Oct, 2022
  • 1 location
A Study of TQ-B3525 in Subjects With Relapsed/Refractory Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma

This is a study to evaluate the efficacy and safety of TQ-B3525 in subjects with relapsed/refractory chronic lymphocytic leukemia/small lymphocytic lymphoma.

  • 0 views
  • 17 Jun, 2021
  • 9 locations
Acalabrutinib, Venetoclax, and Obinutuzumab for Initial Therapy of CLL (AVO)

This research study is evaluating the combination of three drugs - acalabrutinib, venetoclax, and obinutuzumab -- as a possible treatment for chronic lymphocytic leukemia (CLL). The drugs

gilbert's syndrome
obinutuzumab
lymphadenopathy
neutrophil count
lymphocytosis
  • 233 views
  • 19 Jun, 2022
  • 3 locations
Copanlisib Plus Ibrutinib or Acalabrutinib in R/R CLL

six months for relapsed/refractory chronic lymphocytic leukemia (CLL). The names of the study drugs involved in this study are: Copanlisib Ibrutinib

gilbert's syndrome
acalabrutinib
ibrutinib
neutrophil count
lymphocytosis
  • 0 views
  • 02 Jun, 2022
  • 1 location